Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
Author:
Funder
Nektar Therapeutics
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference84 articles.
1. Vinflunine plus capecitabine for advanced breast cancer previously treated with or resistant to anthracycline and resistant to taxane: a phase III study versus capecitabine;Aapro;J. Clin. Oncol.,2014
2. The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial;Al-Batran;Br. J. Cancer,2006
3. Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents;André;Ann. Oncol.,2012
4. Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previously treated with anthracyclines: results of a phase II study in Japan;Aogi;Cancer Chemother. Pharmacol.,2013
5. Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study;Awada;Lancet Oncol.,2013
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of nanoparticle albumin‐bound paclitaxel in taxane‐pretreated metastatic breast cancer patients;Cancer;2024-01-25
2. Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database;Frontiers in Pharmacology;2023-11-10
3. NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence;2023-10-16
4. (Bio)electroanalysis of microtubule-targeting agents used in cancer chemotherapy;Microchemical Journal;2023-09
5. A 10-gene signature associated with elevated levels of NCAPH identifies luminal A breast cancer patients with a risk of relapse;2023-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3